Evidence map›Paper›PMID 38796857›Full record

ArticleEpigenetics2024

Epigenetic editing of

Wanhong He, Haijun Zhu, Sufen Zhang, Guang Shu, Han Lei, Maonan Wang, Gang Yin, Xiaohua Ni, Qihan Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epigenetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Genes · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wanhong HeShanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Haijun ZhuShanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Sufen ZhangShanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Guang ShuDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, China.
Han LeiDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, China.
Maonan WangDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, China.
Gang YinDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, China.
Xiaohua NiShanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Qihan WuShanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.

Funding

Supplementation with Amino Acid Rehabilitative Therapy in TBI (SmART-TBI): A Randomized Placebo-Controlled Trial to Improve SleepI01CX002022 · VA · PORTLAND VA MEDICAL CENTER · PI Miranda M Lim · 2021 to 2026
–
CSRD VA I01 CX002022
6 · The paper itself

Abstract

Drug resistance is the primary contributor to the high mortality rate of ovarian cancer (OC). The loss of

Indexed as

BRCA1 ProteinCisplatinDNA MethylationDrug Resistance, NeoplasmEpigenesis, GeneticOvarian NeoplasmsPhthalazinesPiperazinesPromoter Regions, GeneticAntineoplastic AgentsCell Line, TumorFemaleGene EditingGene Expression Regulation, NeoplasticHumansAntineoplastic AgentsBRCA1 ProteinBRCA1 protein, humanCisplatinolaparibPhthalazinesPiperazinesBRCA1cisplatinOvarian cancer

Identifiers

PMID38796857
PMCPMC11135871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.